Joan Mannick, Tornado Therapeutics CEO
February 16, 2022 09:18 AM EST
Startups
Deals

No­var­tis vet is get­ting an­oth­er shot at mTOR fol­low­ing the im­plo­sion of a longevi­ty pi­o­neer

John Carroll

Editor & Founder

One of the up­starts in the longevi­ty field has roped in some fresh dis­cov­ery as­sets out of No­var­tis — along with a No­var­tis vet to head …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ships two Form 483s to Dr. Red­dy’s for two sep­a­rate sites in In­dia

Pe­ter Marks sin­gle-hand­ed­ly ap­proved Sarep­ta’s gene ther­a­py — what does that mean for every­one else?

Three of Ver­tex’s islet cell ther­a­py pa­tients go in­sulin-in­de­pen­dent

Bris­tol My­ers wins ap­proval for KRAS drug Kraza­ti in col­orec­tal can­cer

Lil­ly’s Zep­bound re­solves sleep ap­nea in obese pa­tients, fur­ther­ing case for la­bel ex­pan­sion

As­traZeneca’s Truqap com­bo flops in Phase 3 triple-neg­a­tive breast can­cer tri­al

A service from the Financial Times